Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002353701 | SCV002654977 | pathogenic | Hereditary cancer-predisposing syndrome | 2021-05-12 | criteria provided, single submitter | clinical testing | The c.616delT pathogenic mutation, located in coding exon 5 of the BRIP1 gene, results from a deletion of one nucleotide at nucleotide position 616, causing a translational frameshift with a predicted alternate stop codon (p.S206Rfs*68). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |
Baylor Genetics | RCV004572323 | SCV005059263 | likely pathogenic | Familial cancer of breast | 2024-02-06 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV004572323 | SCV005405896 | pathogenic | Familial cancer of breast | 2024-08-27 | criteria provided, single submitter | clinical testing | This variant is considered pathogenic. This variant creates a frameshift predicted to result in premature protein truncation. |